Log In
BCIQ
Print this Print this
 

RVT-602, TAK-448

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionOligopeptide kisspeptin receptor agonist
Molecular Target KISS 1 metastatis suppressor (KISS-1) (kisspeptin)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationInfertility
Indication DetailsTreat female Infertility
Regulatory Designation
PartnerMyovant Sciences Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/07/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today